These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10439138)

  • 21. Avoiding deep inspirations increases the maximal response to methacholine without altering sensitivity in non-asthmatics.
    Chapman DG; King GG; Berend N; Diba C; Salome CM
    Respir Physiol Neurobiol; 2010 Sep; 173(2):157-63. PubMed ID: 20688195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doses and models in risk assessment analysis for bronchial hyperresponsiveness.
    de Marco R; Bugiani M; Zanolin E; Verlato G; Rijcken B
    J Clin Epidemiol; 1998 Jan; 51(1):19-28. PubMed ID: 9467631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep inhalation bronchoprotection.
    Cockcroft DW; Davis BE
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):74-5. PubMed ID: 22727163
    [No Abstract]   [Full Text] [Related]  

  • 24. Methacholine Challenge Testing: A Novel Method for Measuring PD
    Davis BE; Simonson SK; Blais CM; Cockcroft DW
    Chest; 2017 Dec; 152(6):1251-1257. PubMed ID: 28923758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity induced bronchopulmonary hyperresponsiveness in Tunisian women.
    Chouchane A; Miâdi-Messaoud H; Ghannouchi I; Rouatbi S; Zbidi A; Tabka Z; Ben-Jebria A
    Int J Obes (Lond); 2010 Jun; 34(6):1078-85. PubMed ID: 20231846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosimetry counts: molecular hypersensitivity may not drive pulmonary hyperresponsiveness.
    Moss OR; Oldham MJ
    J Aerosol Med; 2006; 19(4):555-64. PubMed ID: 17196083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methacholine inhaled challenge: study of correlation among different indices expressing the result.
    Clini E; Vitacca M; Scalvini S; Quadri A; Foglio K
    Monaldi Arch Chest Dis; 1996 Jun; 51(3):194-8. PubMed ID: 8766192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time intervals (3' or 5') between dose steps can influence methacholine challenge test.
    Mariotta S; Sposato B; Ricci A; De Clementi F; Mannino F
    Lung; 2005; 183(1):1-11. PubMed ID: 15793663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchial hyperresponsiveness in irritable bowel syndrome.
    Jun DW; Lee OY; Yoon HJ; Lee HL; Yoon BC; Choi HS; Lee MH; Lee DH; Kee CS
    Dig Dis Sci; 2005 Sep; 50(9):1688-91. PubMed ID: 16133970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a 1-concentration-4-step dosimeter protocol for methacholine testing.
    Merget R; Jörres RA; Heinze E; Haufs MG; Taeger D; Brüning T
    Respir Med; 2009 Apr; 103(4):607-13. PubMed ID: 19010655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Blais CM; Davis BE; Cockcroft DW
    Respir Res; 2017 Aug; 18(1):146. PubMed ID: 28768531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenging the two-minute tidal breathing challenge test.
    Lexmond AJ; Hagedoorn P; Frijlink HW; de Boer AH
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):380-6. PubMed ID: 23509936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in nebulizer output and weight output from Mefar dosimeter: implications for multicentre studies.
    Ward RJ; Reid DW; Walters EH
    Eur Respir J; 1997 Oct; 10(10):2436-7. PubMed ID: 9387980
    [No Abstract]   [Full Text] [Related]  

  • 34. The physical and biological doses of methacholine are different for Mefar MB3 and Jaeger APS sidestream nebulizers.
    Praml G; Scharrer E; de la Motte D; Nowak D; Scheuch G; Sommerer K; Radon K
    Chest; 2005 Nov; 128(5):3585-9. PubMed ID: 16304317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimeter methacholine challenge: comparison of maximal versus submaximal inhalations.
    Todd DC; Davis BE; Hurst TS; Cockcroft DW
    J Allergy Clin Immunol; 2004 Sep; 114(3):517-9. PubMed ID: 15356550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methacholine challenge tests: sample sizes required in crossover trials.
    Neuhäuser M; Jöckel KH
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):27-30. PubMed ID: 16425968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of bronchial hypersensitivity in patients with bronchial asthma].
    Ubaĭdullaev AM; Uzakova GT
    Ter Arkh; 2000; 72(8):17-9. PubMed ID: 11019419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of diagnostic validity of mannitol and methacholine challenges and relationship to clinical status and airway inflammation in steroid-naïve asthmatic patients.
    Porpodis K; Domvri K; Kontakiotis T; Fouka E; Kontakioti E; Zarogoulidis K; Papakosta D
    J Asthma; 2017 Jun; 54(5):520-529. PubMed ID: 27686218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep inspiration avoidance and airway response to methacholine: Influence of body mass index.
    Boulet LP; Turcotte H; Boulet G; Simard B; Robichaud P
    Can Respir J; 2005 Oct; 12(7):371-6. PubMed ID: 16307028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of deep inspiration on methacholine dose-response curves in normal subjects.
    Moore BJ; Verburgt LM; King GG; Paré PD
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1278-81. PubMed ID: 9351635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.